科研製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/06/26 | 5,970 | 5,990 | 5,940 | 5,980 | ±0 | ±0% | 90,300 |
2017/06/23 | 5,960 | 6,000 | 5,950 | 5,980 | +20 | +0.3% | 105,500 |
2017/06/22 | 5,980 | 5,980 | 5,940 | 5,960 | +30 | +0.5% | 86,900 |
2017/06/21 | 5,930 | 5,960 | 5,890 | 5,930 | ±0 | ±0% | 115,100 |
2017/06/20 | 5,970 | 5,970 | 5,920 | 5,930 | +10 | +0.2% | 162,900 |
2017/06/19 | 5,880 | 5,950 | 5,880 | 5,920 | +40 | +0.7% | 103,100 |
2017/06/16 | 5,950 | 5,950 | 5,870 | 5,880 | -40 | -0.7% | 164,000 |
2017/06/15 | 5,870 | 5,930 | 5,850 | 5,920 | ±0 | ±0% | 229,500 |
2017/06/14 | 5,990 | 6,010 | 5,910 | 5,920 | -70 | -1.2% | 141,300 |
2017/06/13 | 5,970 | 6,040 | 5,970 | 5,990 | +40 | +0.7% | 171,500 |
2017/06/12 | 5,950 | 5,950 | 5,900 | 5,950 | -30 | -0.5% | 239,000 |
2017/06/09 | 6,020 | 6,060 | 5,970 | 5,980 | -50 | -0.8% | 170,700 |
2017/06/08 | 6,100 | 6,100 | 6,020 | 6,030 | -60 | -1% | 206,100 |
2017/06/07 | 6,140 | 6,150 | 6,080 | 6,090 | -60 | -1% | 142,600 |
2017/06/06 | 6,280 | 6,300 | 6,140 | 6,150 | -170 | -2.7% | 209,600 |
2017/06/05 | 6,220 | 6,330 | 6,160 | 6,320 | -200 | -3.1% | 425,100 |
2017/06/02 | 6,550 | 6,560 | 6,490 | 6,520 | -40 | -0.6% | 179,100 |
2017/06/01 | 6,430 | 6,560 | 6,430 | 6,560 | +180 | +2.8% | 154,100 |
2017/05/31 | 6,480 | 6,500 | 6,360 | 6,380 | -150 | -2.3% | 193,100 |
2017/05/30 | 6,570 | 6,590 | 6,510 | 6,530 | +10 | +0.2% | 116,900 |
2017/05/29 | 6,560 | 6,590 | 6,510 | 6,520 | -40 | -0.6% | 105,000 |
2017/05/26 | 6,580 | 6,600 | 6,540 | 6,560 | -10 | -0.2% | 131,000 |
2017/05/25 | 6,580 | 6,630 | 6,550 | 6,570 | +10 | +0.2% | 105,600 |
2017/05/24 | 6,600 | 6,610 | 6,510 | 6,560 | -40 | -0.6% | 184,000 |
2017/05/23 | 6,620 | 6,650 | 6,560 | 6,600 | +40 | +0.6% | 146,700 |
2017/05/22 | 6,600 | 6,600 | 6,530 | 6,560 | -50 | -0.8% | 153,800 |
2017/05/19 | 6,680 | 6,680 | 6,560 | 6,610 | -70 | -1% | 154,300 |
2017/05/18 | 6,750 | 6,800 | 6,630 | 6,680 | +30 | +0.5% | 195,500 |
2017/05/17 | 6,680 | 6,710 | 6,610 | 6,650 | -60 | -0.9% | 155,600 |
2017/05/16 | 6,800 | 6,820 | 6,670 | 6,710 | -60 | -0.9% | 211,500 |
2017/05/15 | 6,730 | 6,780 | 6,720 | 6,770 | ±0 | ±0% | 188,900 |
2017/05/12 | 6,760 | 6,830 | 6,740 | 6,770 | ±0 | ±0% | 192,700 |
2017/05/11 | 6,870 | 6,880 | 6,740 | 6,770 | -120 | -1.7% | 275,900 |
2017/05/10 | 6,940 | 6,970 | 6,650 | 6,890 | -60 | -0.9% | 494,000 |
2017/05/09 | 6,810 | 6,950 | 6,800 | 6,950 | +80 | +1.2% | 151,000 |
2017/05/08 | 6,810 | 6,900 | 6,810 | 6,870 | +160 | +2.4% | 272,900 |
2017/05/02 | 6,690 | 6,740 | 6,680 | 6,710 | +40 | +0.6% | 119,600 |
2017/05/01 | 6,610 | 6,670 | 6,580 | 6,670 | +60 | +0.9% | 157,100 |
2017/04/28 | 6,550 | 6,610 | 6,540 | 6,610 | +100 | +1.5% | 144,100 |
2017/04/27 | 6,550 | 6,590 | 6,480 | 6,510 | -120 | -1.8% | 190,200 |
2017/04/26 | 6,600 | 6,640 | 6,550 | 6,630 | +80 | +1.2% | 164,100 |
2017/04/25 | 6,570 | 6,590 | 6,510 | 6,550 | -20 | -0.3% | 115,800 |
2017/04/24 | 6,500 | 6,570 | 6,490 | 6,570 | +110 | +1.7% | 138,900 |
2017/04/21 | 6,400 | 6,460 | 6,360 | 6,460 | +90 | +1.4% | 133,100 |
2017/04/20 | 6,380 | 6,420 | 6,310 | 6,370 | -10 | -0.2% | 166,200 |
2017/04/19 | 6,320 | 6,410 | 6,320 | 6,380 | +10 | +0.2% | 168,800 |
2017/04/18 | 6,300 | 6,380 | 6,260 | 6,370 | +40 | +0.6% | 141,600 |
2017/04/17 | 6,080 | 6,340 | 6,080 | 6,330 | +180 | +2.9% | 163,900 |
2017/04/14 | 6,280 | 6,280 | 6,130 | 6,150 | -110 | -1.8% | 142,200 |
2017/04/13 | 6,260 | 6,280 | 6,220 | 6,260 | ±0 | ±0% | 149,800 |
1951~
2000
件表示中 / 3725件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
科研薬 | 384,400円 | -6.4% | -71.8% | 4.94% | 42.94倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
ジーエヌアイ | 376,500円 | +21.7% | +999.9% | 0.00% | 15.77倍 | 5.22倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
東和薬品 | 295,300円 | +7.9% | -3.3% | 2.71% | 8.21倍 | 0.85倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ゼリア新薬 | 204,800円 | +3.1% | -6.5% | 2.34% | 9.50倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム